{
  "success": true,
  "pagesUsed": [
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-2.5-pro",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "LY900018",
        "type": {
          "id": "7db29be5-03e8-4354-937c-86ebf9fe7c79",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "aaf07d76-8d8f-4b4f-9327-e56b56f8142d",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Nasal glucagon (LY900018) is a powder formulation of human glucagon for the rescue treatment of hypoglycemia.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "GlucaGen",
        "type": {
          "id": "11edc40d-fe1a-4da0-aa6e-d1210c5b2a74",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "c167ce67-a2e0-4a79-a520-455c7b5a9cac",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Intramuscular glucagon (IMG) used as an active comparator.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Human regular insulin",
        "type": {
          "id": "9934de8d-5e83-4ed5-bf31-3eeb20eff52d",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "56d464ff-5d99-4e02-bcc8-49ac0c78b10e",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Administered via IV infusion to induce hypoglycemia as part of the study procedure.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "IV glucose",
        "type": {
          "id": "1e061702-6b21-4e6b-ba19-4d2eb994b92a",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "06da14f7-4e8e-4462-a5f5-c3dde5925adf",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Administered if a patient has an insufficient response to glucagon administration.",
        "productIds": [
          "prod_4"
        ],
        "administrationIds": [
          "admin_4"
        ]
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "LY900018",
        "administrableDoseForm": {
          "id": "d668f24a-dc09-4f93-84ff-3c8c94631400",
          "code": "C42970",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Powder",
          "standardCode": {
            "id": "d1d8f5a6-3a18-4b58-9ad9-17b7763498f3",
            "code": "C42970",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Powder",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "4509173c-e97d-4769-8c19-8bf8904c4bc1",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "3 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Lilly"
      },
      {
        "id": "prod_2",
        "name": "GlucaGen",
        "administrableDoseForm": {
          "id": "07a6c3a5-e0c0-4fe3-9980-c7db2c775fd9",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "ace84ead-136e-485e-a29c-22e195c1b8f0",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "15bc0ff7-b0e4-441c-8ecf-03d00739da37",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "1 mg",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Novo Nordisk A/S"
      },
      {
        "id": "prod_3",
        "name": "Human regular insulin",
        "administrableDoseForm": {
          "id": "6df91122-7908-4067-8b53-3c139dd411fd",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "56cccd2d-6254-4358-89a6-a0f898cfed18",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "05b44f1e-37cc-4719-a921-213c8a8d7992",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "100 U/mL",
        "substanceIds": [
          "sub_3"
        ]
      },
      {
        "id": "prod_4",
        "name": "IV glucose",
        "administrableDoseForm": {
          "id": "9890c182-25fb-4f34-aaae-a9dffb205d4a",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "34138920-97cf-4d2f-b075-f30cfb263c63",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "8b15f28f-edfc-42aa-846d-b45950ed3059",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "LY900018",
        "instanceType": "Administration",
        "dose": "3 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intranasal",
          "codeSystem": "USDM",
          "decode": "Intranasal"
        },
        "duration": "Single administration per treatment period"
      },
      {
        "id": "admin_2",
        "name": "GlucaGen",
        "instanceType": "Administration",
        "dose": "1 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Single administration per treatment period"
      },
      {
        "id": "admin_3",
        "name": "Human regular insulin infusion",
        "instanceType": "Administration",
        "dose": "2 mU/kg/min, adjustable up to 3 mU/kg/min for T1DM or 4 mU/kg/min for T2DM",
        "doseFrequency": "Continuous infusion",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until bedside plasma glucose level is <60 mg/dL"
      },
      {
        "id": "admin_4",
        "name": "IV glucose rescue",
        "instanceType": "Administration",
        "dose": "As deemed clinically necessary",
        "doseFrequency": "As needed",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until hypoglycemia is resolved"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "glucagon",
        "instanceType": "Substance",
        "description": "Active ingredient in LY900018 and GlucaGen. A synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon."
      },
      {
        "id": "sub_2",
        "name": "human regular insulin",
        "instanceType": "Substance",
        "description": "Active ingredient used to induce hypoglycemia."
      },
      {
        "id": "sub_3",
        "name": "glucose",
        "instanceType": "Substance",
        "description": "Active ingredient for rescue treatment of hypoglycemia."
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "Nasal delivery device",
        "instanceType": "MedicalDevice",
        "manufacturer": "Lilly"
      }
    ],
    "summary": {
      "interventionCount": 4,
      "productCount": 4,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "LY900018",
        "role": "Investigational Product",
        "description": "Nasal glucagon (LY900018) is a powder formulation of human glucagon for the rescue treatment of hypoglycemia."
      },
      {
        "name": "GlucaGen",
        "role": "Comparator",
        "description": "Intramuscular glucagon (IMG) used as an active comparator."
      },
      {
        "name": "Human regular insulin",
        "role": "Concomitant Medication",
        "description": "Administered via IV infusion to induce hypoglycemia as part of the study procedure."
      },
      {
        "name": "IV glucose",
        "role": "Rescue Medication",
        "description": "Administered if a patient has an insufficient response to glucagon administration."
      }
    ],
    "products": [
      {
        "name": "LY900018",
        "doseForm": "Nasal powder",
        "strength": "3 mg",
        "manufacturer": "Lilly"
      },
      {
        "name": "GlucaGen",
        "doseForm": "Powder for injection",
        "strength": "1 mg",
        "manufacturer": "Novo Nordisk A/S"
      },
      {
        "name": "Human regular insulin",
        "doseForm": "Solution for infusion",
        "strength": "100 U/mL",
        "manufacturer": null
      },
      {
        "name": "IV glucose",
        "doseForm": "Solution for infusion",
        "strength": null,
        "manufacturer": null
      }
    ],
    "substances": [
      {
        "name": "glucagon",
        "description": "Active ingredient in LY900018 and GlucaGen. A synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon."
      },
      {
        "name": "human regular insulin",
        "description": "Active ingredient used to induce hypoglycemia."
      },
      {
        "name": "glucose",
        "description": "Active ingredient for rescue treatment of hypoglycemia."
      }
    ],
    "administrations": [
      {
        "name": "LY900018",
        "dose": "3 mg",
        "frequency": "Single dose",
        "route": "Intranasal",
        "duration": "Single administration per treatment period"
      },
      {
        "name": "GlucaGen",
        "dose": "1 mg",
        "frequency": "Single dose",
        "route": "Intramuscular",
        "duration": "Single administration per treatment period"
      },
      {
        "name": "Human regular insulin infusion",
        "dose": "2 mU/kg/min, adjustable up to 3 mU/kg/min for T1DM or 4 mU/kg/min for T2DM",
        "frequency": "Continuous infusion",
        "route": "Intravenous",
        "duration": "Until bedside plasma glucose level is <60 mg/dL"
      },
      {
        "name": "IV glucose rescue",
        "dose": "As deemed clinically necessary",
        "frequency": "As needed",
        "route": "Intravenous",
        "duration": "Until hypoglycemia is resolved"
      }
    ],
    "devices": [
      {
        "name": "Nasal delivery device",
        "manufacturer": "Lilly",
        "purpose": "Included as part of the investigational drug product (LY900018) to deliver the contained drug constituent into the nasal cavity."
      }
    ]
  }
}